NCT06644339|Not Yet RecruitingDMC
Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence
DIALOG
Loading search results
DIALOG
Sponsor study identifier
interventional
500
1 country
1
Study Start
October 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 28, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
DIALOG is a study to assess the efficacy and safety of remote patient monitoring using virtual operator voice technologies and a business intelligence (BI) system for timely detection, prevention of early complications, worsening of the condition, and other adverse events in patients who have been discharged from the hospital.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 3, 2024
Actual (reported)October 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 16, 2024
Actual (reported)February 28, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
cardiovascular mortality
mortality rate
an average, 1 month after randomization
all-cause mortality
mortality rate
an average, 1 months after randomization
complications, decompensations
rate of complications and exacerbations of the main disease
an average, 1 month after randomization
Patients with chronic heart failure who was hospitalized due to decompensation of their condition. Their condition should be stabilized before discharge. Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands to automate data collection and obtain information about the patient's well-being and his vital signs (blood pressure, heart rate, weight) related to heart failure.
Patients with diabetes mellitus who was hospitalized with unstable glucose level. Their condition should be stabilized before discharge. Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands to automate data collection and obtain information about the patient's well-being and his vital signs (blood pressure, heart rate, weight, glucose) related to diabetes mellitus.
Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands on the "question-answer" principle. It allows us to automate data collection and obtain information about the patient's well-being and his vital signs (blood pressure, heart rate, weight) depending on disease. Follow-up and management of disease provided by specialists at participating institutions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), University Clinical Hospital No.1
Moscow, 119048, Russia
Maria Kozhevnikova, Professor
The Sechenov First Moscow State Medical University
First Submitted
October 3, 2024
First Posted
October 16, 2024
Study Start
October 15, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 28, 2025
Estimated (date passed)achievement target or maximally tolerated doses
an average, 1 month after randomization
satisfaction
an average, 1 month after randomization
changes in medical adherence
an average, 1 month after randomization
Patients with arterial hypertension who was hospitalized with unstable arterial pressure. Their condition should be stabilized before discharge. Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands to automate data collection and obtain information about the patient's well-being and his vital signs (blood pressure, heart rate, hypotension sings, signs of damage to target organs).
Patients with any lymphoproliferative disease who is undergoing chemotherapy. Their condition should be stabilized before discharge. Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands to automate data collection and obtain information about the patient's well-being and his vital signs (blood pressure, heart rate) related to chemotherapy complications.
Patients who underwent total knee replacement. Their condition should be stabilized before discharge. Robotic remote monitoring of patients using unique algorithms developed for virtual operator speech technology and a BI system by voice commands to automate data collection and obtain information about the patient's well-being and his vital signs (pain, fever) related to replacement complications.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 16, 2024
Record last verified: 2024-10
According to the Local Ethics Committee\'s rules, we are not allowed to provide this data.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: